These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5764023)

  • 1. Metabolic fate of tritiated busulfan in man.
    Vodopick H; Hamilton HE; Jackson HL; Peng CT; Sheets RF
    J Lab Clin Med; 1969 Feb; 73(2):266-76. PubMed ID: 5764023
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety profile of hydroxyurea in the treatment of patients with Philadelphia-negative chronic myeloproliferative disorders.
    Randi ML; Ruzzon E; Luzzatto G; Tezza F; Girolami A; Fabris F
    Haematologica; 2005 Feb; 90(2):261-2. PubMed ID: 15710584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of platelets and virus-like particles by busulfan in myeloproliferative disorders.
    Fuscaldo AA; Erlick BJ; Brodsky I; Fuscaldo KE
    Leuk Res; 1980; 4(1):105-17. PubMed ID: 6157962
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of myeloproliferative diseases.
    Sellei C
    Ther Hung; 1966; 14(4):135-6. PubMed ID: 5228101
    [No Abstract]   [Full Text] [Related]  

  • 5. Erythroleukemia-like syndrome due to busulfan toxicity in polycythemia vera.
    Pezzimenti JF; Kim HC; Lindenbaum J
    Cancer; 1976 Dec; 38(6):2242-6. PubMed ID: 1069602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Busulphan and the lungs. Absence of lung function disturbance in patients treated with busulphan.
    Comhaire F; Van Hove W; Van Ganse W; Van der Straeten M
    Scand J Respir Dis; 1972; 53(5):265-73. PubMed ID: 4508954
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy of haematological malignancies. Prognostic significance.
    Klener P
    Acta Univ Carol Med Monogr; 1979; 90():7-127. PubMed ID: 400423
    [No Abstract]   [Full Text] [Related]  

  • 8. JAK2 inhibitors: not the next imatinib but researchers see other possibilities.
    Garber K
    J Natl Cancer Inst; 2009 Jul; 101(14):980-2. PubMed ID: 19584324
    [No Abstract]   [Full Text] [Related]  

  • 9. Stimulation in vitro of cells from patients with myeloproliferative disorders.
    Pegrum GD
    Blut; 1967 Feb; 14(5):277-83. PubMed ID: 5227692
    [No Abstract]   [Full Text] [Related]  

  • 10. [Case of myelosan-induced hematopoietic aplasia in erythremia].
    Demidova AV; Siver AP; Pogorzhel'skiĭ VI
    Ter Arkh; 1977; 49(2):133-4. PubMed ID: 860217
    [No Abstract]   [Full Text] [Related]  

  • 11. Hydroxyurea induced skin ulceration in myeloproliferative disorders.
    McLintock C; Ockelford PA
    Aust N Z J Med; 2000 Jun; 30(3):373-6. PubMed ID: 10914756
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hypervitaminemia B-12 in leukemia and myeloproliferative syndromes].
    Zittoun J; Zittoun R; Guernet M; Bilski-Pasquier G; Bousser J
    Rev Fr Etud Clin Biol; 1968; 13(7):684-94. PubMed ID: 5248357
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of busulfan on oncornavirus-like activity in platelets and chromosomes in polycythemia vera and essential thrombocythemia.
    Brodsky I; Fuscaldo AA; Erlick BJ; Fuscaldo KE
    J Natl Cancer Inst; 1977 Jul; 59(1):61-7. PubMed ID: 69034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When to use chemotherapy for chronic hematopoietic neoplasms.
    Yu KP; Krakoff IH
    Postgrad Med; 1968 May; 43(5):176-83. PubMed ID: 5239464
    [No Abstract]   [Full Text] [Related]  

  • 15. [New molecular markers within the chronic myeloproliferative disorders. I: the PRV-1 gene].
    Larsen TS; Pallisgaard N; Christensen JH; Gram-Hansen P; Kerndrup GB; Møller MB; Hasselbalch HC
    Ugeskr Laeger; 2006 Sep; 168(39):3295-9. PubMed ID: 17032591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radioactive phosphorus (32P); an old but not bad treatment for polycythemia vera].
    Tesselaar ME; Wijermans PW; Metsaars JA; Gerrits WB; Haak HL
    Ned Tijdschr Geneeskd; 1996 Sep; 140(38):1900-2. PubMed ID: 8927166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin B14-binding protein in polycythemia vera plasma.
    Hall CA; Finkler AE
    J Lab Clin Med; 1969 Jan; 73(1):60-9. PubMed ID: 5762165
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hydroxyurea-induced leg ulcers in patients with chronic myeloproliferative disorders].
    Olesen LH; Pedersen BB
    Ugeskr Laeger; 2001 Dec; 163(49):6908-11. PubMed ID: 11766504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The management of elderly patients with myeloproliferative disorders.
    Tura S
    Hematol Oncol; 1993; 11 Suppl 1():39-41. PubMed ID: 8486340
    [No Abstract]   [Full Text] [Related]  

  • 20. Statins in the treatment of polycythaemia vera and allied disorders: an antithrombotic and cytoreductive potential?
    Hasselbalch HC; Riley CH
    Leuk Res; 2006 Oct; 30(10):1217-25. PubMed ID: 16483650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.